Study aid only. Verify against current guidelines, primary literature, staging manuals, and prescribing information before clinical use.

← All algorithms  ·  Related notes →

Early-stage TNBC

Early stage TNBC < 2 cm and node negative < 1 cm Surgery Observe (T1a) or chemotherapy 1–2 cm Surgery Chemotherapy ≥ 2 cm or node positive TC → AC + pembrolizumab KEYNOTE-522 (preferred, high risk) ↗ Surgery pCR Pembrolizumab KEYNOTE-522 ↗ Residual disease Pembro + capecitabine BRCAwt · KEYNOTE-522, CREATE-X ↗ Pembro + olaparib gBRCA · KEYNOTE-522, OlympiA ↗